269 related articles for article (PubMed ID: 30943767)
1. Predictors of Clinical Evolution in Prehypertrophic Fabry Disease.
Camporeale A; Pieroni M; Pieruzzi F; Lusardi P; Pica S; Spada M; Mignani R; Burlina A; Bandera F; Guazzi M; Graziani F; Crea F; Greiser A; Boveri S; Ambrogi F; Lombardi M
Circ Cardiovasc Imaging; 2019 Apr; 12(4):e008424. PubMed ID: 30943767
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping.
Réant P; Testet E; Reynaud A; Bourque C; Michaud M; Rooryck C; Goizet C; Lacombe D; de-Précigout V; Peyrou J; Cochet H; Lafitte S
Int J Cardiovasc Imaging; 2020 Jul; 36(7):1333-1342. PubMed ID: 32385539
[TBL] [Abstract][Full Text] [Related]
3. Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
Nordin S; Kozor R; Medina-Menacho K; Abdel-Gadir A; Baig S; Sado DM; Lobascio I; Murphy E; Lachmann RH; Mehta A; Edwards NC; Ramaswami U; Steeds RP; Hughes D; Moon JC
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1673-1683. PubMed ID: 29778854
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Phenotype of Prehypertrophic Fabry Disease.
Nordin S; Kozor R; Baig S; Abdel-Gadir A; Medina-Menacho K; Rosmini S; Captur G; Tchan M; Geberhiwot T; Murphy E; Lachmann R; Ramaswami U; Edwards NC; Hughes D; Steeds RP; Moon JC
Circ Cardiovasc Imaging; 2018 Jun; 11(6):e007168. PubMed ID: 29853467
[TBL] [Abstract][Full Text] [Related]
5. Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.
Nordin S; Kozor R; Vijapurapu R; Augusto JB; Knott KD; Captur G; Treibel TA; Ramaswami U; Tchan M; Geberhiwot T; Steeds RP; Hughes DA; Moon JC
Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009430. PubMed ID: 31826677
[TBL] [Abstract][Full Text] [Related]
6. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
[TBL] [Abstract][Full Text] [Related]
7. Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
Augusto JB; Nordin S; Vijapurapu R; Baig S; Bulluck H; Castelletti S; Alfarih M; Knott K; Captur G; Kotecha T; Ramaswami U; Tchan M; Geberhiwot T; Fontana M; Steeds RP; Hughes D; Kozor R; Moon JC
Circ Cardiovasc Imaging; 2020 Mar; 13(3):e010171. PubMed ID: 32114828
[TBL] [Abstract][Full Text] [Related]
8. Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.
Vijapurapu R; Nordin S; Baig S; Liu B; Rosmini S; Augusto J; Tchan M; Hughes DA; Geberhiwot T; Moon JC; Steeds RP; Kozor R
Heart; 2019 Mar; 105(6):470-476. PubMed ID: 30282640
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular radial strain impairment precedes hypertrophy in Anderson-Fabry disease.
Spinelli L; Giugliano G; Imbriaco M; Esposito G; Nappi C; Riccio E; Ponsiglione A; Pisani A; Cuocolo A; Trimarco B
Int J Cardiovasc Imaging; 2020 Aug; 36(8):1465-1476. PubMed ID: 32306159
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.
Pica S; Sado DM; Maestrini V; Fontana M; White SK; Treibel T; Captur G; Anderson S; Piechnik SK; Robson MD; Lachmann RH; Murphy E; Mehta A; Hughes D; Kellman P; Elliott PM; Herrey AS; Moon JC
J Cardiovasc Magn Reson; 2014 Dec; 16(1):99. PubMed ID: 25475749
[TBL] [Abstract][Full Text] [Related]
11. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
Augusto JB; Johner N; Shah D; Nordin S; Knott KD; Rosmini S; Lau C; Alfarih M; Hughes R; Seraphim A; Vijapurapu R; Bhuva A; Lin L; Ojrzyńska N; Geberhiwot T; Captur G; Ramaswami U; Steeds RP; Kozor R; Hughes D; Moon JC; Namdar M
Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):790-799. PubMed ID: 32514567
[TBL] [Abstract][Full Text] [Related]
12. Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR.
Kozor R; Grieve SM; Tchan MC; Callaghan F; Hamilton-Craig C; Denaro C; Moon JC; Figtree GA
Heart; 2016 Feb; 102(4):298-302. PubMed ID: 26729695
[TBL] [Abstract][Full Text] [Related]
13. Trabecular complexity as an early marker of cardiac involvement in Fabry disease.
Camporeale A; Moroni F; Lazzeroni D; Garibaldi S; Pieroni M; Pieruzzi F; Lusardi P; Spada M; Mignani R; Burlina A; Carubbi F; Econimo L; Battaglia Y; Graziani F; Pica S; Chow K; Camici PG; Lombardi M
Eur Heart J Cardiovasc Imaging; 2022 Jan; 23(2):200-208. PubMed ID: 33486507
[TBL] [Abstract][Full Text] [Related]
14. Diffuse Myocardial Fibrosis Reduces Electrocardiographic Voltage Measures of Left Ventricular Hypertrophy Independent of Left Ventricular Mass.
Maanja M; Wieslander B; Schlegel TT; Bacharova L; Abu Daya H; Fridman Y; Wong TC; Schelbert EB; Ugander M
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28111363
[TBL] [Abstract][Full Text] [Related]
15. Correlation between right ventricular T
Jellis CL; Yingchoncharoen T; Gai N; Kusunose K; Popović ZB; Flamm S; Kwon D
Int J Cardiovasc Imaging; 2018 Jan; 34(1):55-65. PubMed ID: 28357724
[TBL] [Abstract][Full Text] [Related]
16. Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy.
Toro R; Perez-Isla L; Doxastaquis G; Barba MA; Gallego AR; Pintos G; Barbados FJ; Mangas A; Zamorano JL
Int J Cardiol; 2009 Feb; 132(1):38-44. PubMed ID: 18691784
[TBL] [Abstract][Full Text] [Related]
17. The value of electrocardiography and echocardiography in distinguishing Fabry disease from sarcomeric hypertrophic cardiomyopathy.
Junqua N; Legallois D; Segard S; Lairez O; Réant P; Goizet C; Maillard H; Charron P; Milliez P; Labombarda F
Arch Cardiovasc Dis; 2020; 113(8-9):542-550. PubMed ID: 32771348
[TBL] [Abstract][Full Text] [Related]
18. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
19. Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients.
Nojiri A; Anan I; Morimoto S; Kawai M; Sakuma T; Kobayashi M; Kobayashi H; Ida H; Ohashi T; Eto Y; Shibata T; Yoshimura M; Hongo K
J Cardiol; 2020 Jan; 75(1):27-33. PubMed ID: 31623930
[TBL] [Abstract][Full Text] [Related]
20. Early diastolic mitral annular velocity and color M-mode flow propagation velocity in the evaluation of left ventricular diastolic function in patients with Fabry disease.
Palecek T; Linhart A; Lubanda JC; Magage S; Karetova D; Bultas J; Aschermann M
Heart Vessels; 2006 Jan; 21(1):13-9. PubMed ID: 16440143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
